细菌性阴道病的抗菌治疗：现有和新兴疗法。
Antibacterial treatment of bacterial vaginosis: current and emerging therapies.
机构信息
Pôle Enfance et Famille, Conseil Général du Val-de-Marne, Créteil, France.
出版信息
Int J Womens Health. 2011;3:295-305. doi: 10.2147/IJWH.S23814. Epub 2011 Aug 23.
Abstract
Bacterial vaginosis is a common cause of malodorous vaginal discharge. It is also associated with sexually transmitted infections and adverse pregnancy outcomes. The magnitude of the gynecological and obstetrical consequences has stimulated therapeutic research and led to the testing of several therapies. The objective of this work is to present the currently available therapeutic strategies for the treatment of bacterial vaginosis and associated recommendations, and discuss the emerging therapies.
摘要
细菌性阴道病是一种常见的有异味阴道分泌物的原因。它也与性传播感染和不良妊娠结局有关。妇科和产科后果的严重程度刺激了治疗研究，并导致了几种治疗方法的测试。本工作的目的是介绍目前可用于治疗细菌性阴道病和相关建议的治疗策略，并讨论新兴的治疗方法。
相似文献
1
Antibacterial treatment of bacterial vaginosis: current and emerging therapies.细菌性阴道病的抗菌治疗：现有和新兴疗法。
Int J Womens Health. 2011;3:295-305. doi: 10.2147/IJWH.S23814. Epub 2011 Aug 23.
2
Bacterial vaginosis: current review with indications for asymptomatic therapy.细菌性阴道病：当前综述及无症状治疗指征
Am J Obstet Gynecol. 1991 Oct;165(4 Pt 2):1210-7. doi: 10.1016/s0002-9378(12)90729-2.
3
Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.外阴阴道炎：滴虫病、外阴阴道念珠菌病和细菌性阴道病的筛查与管理。
J Obstet Gynaecol Can. 2015 Mar;37(3):266-274. doi: 10.1016/S1701-2163(15)30316-9.
4
Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis.与阴道念珠菌病相比，细菌性阴道病相关的高风险行为习惯。
Obstet Gynecol. 2005 Jul;106(1):105-14. doi: 10.1097/01.AOG.0000163247.78533.7b.
5
Bacterial vaginosis: a threat to reproductive health? Historical perspectives, current knowledge, controversies and research demands.细菌性阴道病：对生殖健康的威胁？历史视角、当前认知、争议与研究需求
Eur J Contracept Reprod Health Care. 2000 Sep;5(3):208-19. doi: 10.1080/13625180008500398.
6
[Bacterial vaginosis].[细菌性阴道病]
Enferm Infecc Microbiol Clin. 2016 Jul;34 Suppl 3:14-8. doi: 10.1016/S0213-005X(16)30214-2.
7
Bacterial vaginosis: many questions--any answers?细菌性阴道病：诸多疑问——可有答案？
Curr Opin Pediatr. 2005 Aug;17(4):473-9. doi: 10.1097/01.mop.0000170516.35272.45.
8
Bacterial Vaginosis Biofilms: Challenges to Current Therapies and Emerging Solutions.细菌性阴道病生物膜：当前治疗面临的挑战与新出现的解决方案
Front Microbiol. 2016 Jan 20;6:1528. doi: 10.3389/fmicb.2015.01528. eCollection 2015.
9
Targeted point-of-care testing compared with syndromic management of urogenital infections in women (WISH): a cross-sectional screening and diagnostic accuracy study.靶向即时检测与女性泌尿生殖系统感染的症状管理（WISH）比较：一项横断面筛查和诊断准确性研究。
Lancet Infect Dis. 2019 Jun;19(6):658-669. doi: 10.1016/S1473-3099(18)30724-2. Epub 2019 Apr 25.
10
Bacterial vaginosis.细菌性阴道病
Prim Care Update Ob Gyns. 2000 Sep 1;7(5):181-185. doi: 10.1016/s1068-607x(00)00043-3.
引用本文的文献
1
Exploring the vaginal ecosystem: insights into host-microbe interactions and microbial community dynamics.探索阴道生态系统：洞悉宿主与微生物的相互作用及微生物群落动态
Infect Immun. 2025 Sep 9;93(9):e0049924. doi: 10.1128/iai.00499-24. Epub 2025 Aug 11.
2
Leveraging the microbiome to combat antibiotic resistant gynecological infections.利用微生物群对抗抗生素耐药性妇科感染。
NPJ Antimicrob Resist. 2025 Apr 23;3(1):32. doi: 10.1038/s44259-025-00106-2.
3
Efficacy and safety of different drugs for the treatment of bacterial vaginosis: a systematic review and network meta-analysis.不同药物治疗细菌性阴道病的疗效和安全性：系统评价和网络荟萃分析。
Front Cell Infect Microbiol. 2024 Oct 11;14:1402346. doi: 10.3389/fcimb.2024.1402346. eCollection 2024.
4
Computational approach for drug discovery against Gardnerella vaginalis in quest for safer and effective treatments for bacterial vaginosis.针对阴道加德纳菌的药物发现计算方法研究，以寻求更安全有效的细菌性阴道病治疗方法。
Sci Rep. 2024 Jul 29;14(1):17437. doi: 10.1038/s41598-024-68443-2.
5
Bacterial Vaginosis (BV) and Vaginal Microbiome Disorders in Women Suffering from Polycystic Ovary Syndrome (PCOS).多囊卵巢综合征（PCOS）女性患者的细菌性阴道病（BV）与阴道微生物群紊乱
Diagnostics (Basel). 2024 Feb 12;14(4):404. doi: 10.3390/diagnostics14040404.
6
Mesh and layered electrospun fiber architectures as vehicles for Lactobacillus acidophilus and Lactobacillus crispatus intended for vaginal delivery.用于阴道递药的嗜酸乳杆菌和卷曲乳杆菌的网格和分层电纺纤维结构载体。
Biomater Adv. 2023 Nov;154:213614. doi: 10.1016/j.bioadv.2023.213614. Epub 2023 Aug 29.
7
Rapid-dissolving electrospun nanofibers for intra-vaginal antibiotic or probiotic delivery.用于阴道内抗生素或益生菌递送的速溶电纺纳米纤维。
Eur J Pharm Biopharm. 2023 Sep;190:81-93. doi: 10.1016/j.ejpb.2023.07.009. Epub 2023 Jul 19.
8
Sorangicin A Is Active against in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment.索拉吉星A在细胞培养、离体输卵管及局部体内治疗中对[具体对象未提及]具有活性。
Antibiotics (Basel). 2023 Apr 22;12(5):795. doi: 10.3390/antibiotics12050795.
9
Formulation and characterization of pressure-assisted microsyringe 3D-printed scaffolds for controlled intravaginal antibiotic release.压力辅助微注射器 3D 打印支架的配方和特性研究，用于控制阴道内抗生素释放。
Int J Pharm. 2023 Jun 25;641:123054. doi: 10.1016/j.ijpharm.2023.123054. Epub 2023 May 18.
10
Lactobacillus crispatus-loaded electrospun fibers yield viable and metabolically active bacteria that kill Gardnerella in vitro.载有卷曲乳杆菌的静电纺纤维产生活菌和代谢活跃的细菌，可在体外杀死加德纳菌。
Eur J Pharm Biopharm. 2023 Jun;187:68-75. doi: 10.1016/j.ejpb.2023.04.011. Epub 2023 Apr 20.
本文引用的文献
1
Preparation and anti-bacterial properties of a temperature-sensitive gel containing silver nanoparticles.含银纳米颗粒的温敏凝胶的制备及其抗菌性能
Pharmazie. 2011 Apr;66(4):272-7.
2
Controlled study on thymol + eugenol vaginal douche versus econazole in vaginal candidiasis and metronidazole in bacterial vaginosis.麝香草酚+丁香酚阴道灌洗与益康唑治疗阴道念珠菌病及甲硝唑治疗细菌性阴道病的对照研究
Arzneimittelforschung. 2011;61(2):126-31. doi: 10.1055/s-0031-1296178.
3
Pilot randomized trial for treatment of bacterial vaginosis using in situ forming metronidazole vaginal gel.使用原位形成甲硝唑阴道凝胶治疗细菌性阴道病的试点随机试验。
J Obstet Gynaecol Res. 2011 Jul;37(7):874-81. doi: 10.1111/j.1447-0756.2010.01457.x. Epub 2011 Mar 16.
4
Prevention of infection after induced abortion: release date October 2010: SFP guideline 20102.人工流产后感染的预防：发布日期 2010 年 10 月：20102 年 SFP 指南。
Contraception. 2011 Apr;83(4):295-309. doi: 10.1016/j.contraception.2010.11.006. Epub 2011 Feb 12.
5
The aetiology of bacterial vaginosis.细菌性阴道病的病因。
J Appl Microbiol. 2011 May;110(5):1105-28. doi: 10.1111/j.1365-2672.2011.04977.x. Epub 2011 Mar 14.
6
In vitro activity of nifuratel on vaginal bacteria: could it be a good candidate for the treatment of bacterial vaginosis?硝呋太尔对阴道细菌的体外活性：它是否可能成为治疗细菌性阴道病的良好候选药物？
Antimicrob Agents Chemother. 2011 May;55(5):2490-2. doi: 10.1128/AAC.01623-10. Epub 2011 Feb 14.
7
The vaginal microbiome: new information about genital tract flora using molecular based techniques.阴道微生物组：使用基于分子的技术获得的关于生殖道菌群的新信息。
BJOG. 2011 Apr;118(5):533-49. doi: 10.1111/j.1471-0528.2010.02840.x. Epub 2011 Jan 20.
8
Inhibitory activity of thymol on native and mature Gardnerella vaginalis biofilms: in vitro study.百里香酚对天然和成熟阴道加德纳菌生物膜的抑制活性：体外研究
Arzneimittelforschung. 2010;60(11):675-81. doi: 10.1055/s-0031-1296346.
9
Tinidazole vs metronidazole for the treatment of bacterial vaginosis.替硝唑与甲硝唑治疗细菌性阴道病的疗效比较。
Am J Obstet Gynecol. 2011 Mar;204(3):211.e1-6. doi: 10.1016/j.ajog.2010.10.898. Epub 2010 Dec 17.
10
Probiotic strategies for the treatment and prevention of bacterial vaginosis.益生菌治疗和预防细菌性阴道病的策略。
Expert Opin Pharmacother. 2010 Dec;11(18):2985-95. doi: 10.1517/14656566.2010.512004.
Zotero 插件